Advertisement

Bisphosphonate Infusion Therapy

  • Todd H. Ruth
  • Veena Graff
Chapter

Abstract

Bisphosphonates (e.g., pamidronate, clodronate, alendronate) are pyrophosphate analogs, traditionally used in the treatment of pathologic conditions associated with abnormal bone metabolism, such as osteoporosis, Paget’s disease, and cancer-related bone pain. Recent research shows encouraging results regarding efficacy in often difficult to treat chronic pain syndromes including complex regional pain syndrome and osteoarthritic low back pain. These results combined with a benign safety profile makes bisphosphonate infusion an intriguing modality for physicians to consider for patients suffering from these conditions.

Keywords

Bisphosphonates Bisphosphonate infusions Complex regional pain syndrome Reflex sympathetic dystrophy syndrome CRPS CRPS-1 Reflex sympathetic dystrophy Chronic pain Chronic low back pain CLBP Alendronate Clodronate Pamidronate Neridronate 

References

  1. 1.
    Yanow J, Pappagallo M, Pillai L. Complex regional pain syndrome (CRPS/RSD) and neuropathic pain: role of intravenous bisphosphonates as analgesics. Sci World J. 2008;8:229–36.CrossRefGoogle Scholar
  2. 2.
    Russell RGG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007;119(Suppl 2):S150–62.CrossRefGoogle Scholar
  3. 3.
    Fleisch H. Bisphosphonates in osteoporosis. European Spine Journal: Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2003;12(Suppl 2):S142–6.  https://doi.org/10.1007/s00586-003-0622-z.
  4. 4.
    Brunner F, Schmid A, Kissling R, Held U, Bachmann LM. Biphosphonates for the therapy of complex regional pain syndrome I–systematic review. Eur J Pain. 2009;13(1):17–21.CrossRefGoogle Scholar
  5. 5.
    Maillefert JF, Chatard C, Owen S, Peere T, Tavernier C, Tebib J. Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis. 1995;54(8):687.CrossRefGoogle Scholar
  6. 6.
    Cortet B, Flipo RM, Coquerelle P, Duquesnoy B, Delcambre B. Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin Rheumatol. 1997;16(1):51–6.CrossRefGoogle Scholar
  7. 7.
    Kubalek I, Fain O, Paries J, Kettaneh A, Thomas M. Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology. 2001;40(12):1394–7.CrossRefGoogle Scholar
  8. 8.
    Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Med. 2004;5(3):276–80.CrossRefGoogle Scholar
  9. 9.
    Breuer B, Pappagallo M, Ongseng F, Chen CI, Goldfarb R. An open-label pilot trial of ibandronate for complex regional pain syndrome. Clin J Pain. 2008;24(8):685–9.CrossRefGoogle Scholar
  10. 10.
    Chevreau M, Romand X, Gaudin P, Juvin R, Baillet A. Bisphosphonates for treatment of Complex Regional Pain Syndrome type 1: a systematic literature review and meta-analysis of randomized controlled trials versus placebo. Joint Bone Spine. 2017;84(4):393–9.CrossRefGoogle Scholar
  11. 11.
    Abdulla AJJ. Use of pamidronate for acute pain relief following osteoporotic vertebral fractures. Rheumatology. 2000;39(5):567–8.CrossRefGoogle Scholar
  12. 12.
    Gangji V, Appelboom T. Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures. Clin Rheumatol. 1999;18(3):266–7.CrossRefGoogle Scholar
  13. 13.
    Armingeat T, Brondino R, Pham T, Legré V, Lafforgue P. Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study. Osteoporos Int. 2006;17(11):1659–65.CrossRefGoogle Scholar
  14. 14.
    Laroche M, Cantogrel S, Jamard B, Constantin A, Zabraniecki L, Cantagrel A, Mazières B. Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study. Clin Rheumatol. 2006;25(5):683–6.CrossRefGoogle Scholar
  15. 15.
    Poujol D, Ristori JM, Dubost JJ, Soubrier M. Efficacy of pamidronate in erosive degenerative disk disease: a pilot study. Joint Bone Spine. 2007;74(6):663–4.CrossRefGoogle Scholar
  16. 16.
    Feld J, Rosner I, Avshovich N, Boulman N, Slobodin G, Rozenbaum M. An open study of pamidronate in the treatment of refractory degenerative lumbar spinal stenosis. Clin Rheumatol. 2009;28(6):715–7.CrossRefGoogle Scholar
  17. 17.
    Pappagallo M, Breuer B, Lin HM, Moberly JB, Tai J, Noto C, et al. A pilot trial of intravenous pamidronate for chronic low back pain. Pain. 2014;155(1):108–17.CrossRefGoogle Scholar
  18. 18.
    Birklein F, Dimova V. Complex regional pain syndrome–up-to-date. Pain Rep. 2017;2(6):e624.CrossRefGoogle Scholar
  19. 19.
    Pamidronate [package insert]. Petah Tikva, Israel. Teva Parenteral Medicines, Inc; 2009.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Todd H. Ruth
    • 1
  • Veena Graff
    • 2
  1. 1.University of Pennsylvania Perelman School of Medicine, Department of Interventional Pain MedicinePhiladelphiaUSA
  2. 2.Department of Anesthesiology and Critical CareUniversity of Pennsylvania Perelman School of MedicinePhiladelphiaUSA

Personalised recommendations